Transplantační medicína

video of Pr Steven Edelman answering to the question: How has Toujeo®’s wall of evidence across diverse diabetes patient populations and situations helped to inform your clinical decision making?

Perspectives on basal insulin use post-GLP-1 RA, EASD, Dr Alice Cheng

What for you are the key findings of the Toujeo® pooled analysis?

In what way does the evidence for Toujeo^® help you to address the considerations for patients who are inadequately controlled on a GLP-1 receptor agonist?

What would you say is the value of the findings in the Toujeo^® pooled analysis and the DELIVER-G study when you consider the management of your patients with type 2 diabetes who are inadequately controlled on GLP-1 receptor agonist?

How does the Toujeo pooled analysis complement DELIVER-G Study